SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001753926-23-000138
Filing Date
2023-02-13
Accepted
2023-02-13 17:24:48
Documents
1
Group Members
BRENDAN O'NEILKEITH COULSTON

Document Format Files

Seq Description Document Type Size
1 SC 13G/A g083403_sc-13ga.htm SC 13G/A 65660
  Complete submission text file 0001753926-23-000138.txt   67454
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Subject) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-42755 | Film No.: 23620091
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3053 FILLMORE ST. SUITE 256 SAN FRANCISCO CA 94123
Business Address 3053 FILLMORE ST. SUITE 256 SAN FRANCISCO CA 94123 415-999-2132
Ionic Ventures, LLC (Filed by) CIK: 0001769419 (see all company filings)

IRS No.: 660889836 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A